Contrasting Reliance (NYSE:RS) & Cerebain Biotech (OTCMKTS:CBBT)

Reliance (NYSE:RS) and Cerebain Biotech (OTCMKTS:CBBT) are both industrials companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Valuation & Earnings

This table compares Reliance and Cerebain Biotech”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Reliance	$14.29 billion	1.37	$739.40 million	$17.20	22.31
Cerebain Biotech	N/A	N/A	N/A	N/A	N/A

Reliance has higher revenue and earnings than Cerebain Biotech.

Institutional and Insider Ownership

79.3% of Reliance shares are held by institutional investors. 0.4% of Reliance shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of current recommendations and price targets for Reliance and Cerebain Biotech, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Reliance	1	5	2	1	2.33
Cerebain Biotech	0	0	0	0	0.00

Reliance currently has a consensus target price of $377.50, suggesting a potential downside of 1.63%. Given Reliance’s stronger consensus rating and higher possible upside, equities analysts clearly believe Reliance is more favorable than Cerebain Biotech.

Profitability

This table compares Reliance and Cerebain Biotech’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Reliance	5.65%	12.51%	8.47%
Cerebain Biotech	N/A	N/A	N/A

Summary

Reliance beats Cerebain Biotech on 10 of the 10 factors compared between the two stocks.

About Reliance

Reliance, Inc. operates as a diversified metal solutions provider and the metals service center company in the United States, Canada, and internationally. The company distributes a line of approximately 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium, and specialty steel products; and provides metals processing services to general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, and heavy industries. It sells its products directly to original equipment manufacturers, which primarily include small machine shops and fabricators. The company was formerly known as Reliance Steel & Aluminum Co. and changed its name to Reliance, Inc. in February 2024. Reliance, Inc. was founded in 1939 and is based in Scottsdale, Arizona.

About Cerebain Biotech

Cerebain Biotech Corp. is a biomedical company, which engages in the creation and clinical development of a minimally invasive implantable device. It focuses on the discovery of products for the treatment of Alzheimer’s disease utilizing Omentum. The company was founded on December 18, 2007 and is headquartered in Costa Mesa, CA.